Claim OwnershipInnovation and the Future of Pharmacovigilance
Subscribed: 0Played: 5
Subscribe
© 2024 Truliant Consulting
Description
"Innovation and the Future of Pharmacovigilance" is a podcast series under our Truliant Talks platform. We dive into the fascinating world of drug safety, exploring ongoing challenges, cutting-edge technology, and future predictions in pharmacovigilance.
Our expert guests provide a wealth of knowledge as they discuss topics from real-world data to post-marketing surveillance, ethical considerations, and beyond. This podcast is an invaluable resource for anyone interested in understanding how innovation is shaping the future of pharmacovigilance. Each episode promises insightful discussions, stimulating ideas, and the chance to keep abreast with the latest trends and issues in the field.
Join us on this journey, deciphering the complex world of pharmacovigilance in an accessible and engaging manner.
Our expert guests provide a wealth of knowledge as they discuss topics from real-world data to post-marketing surveillance, ethical considerations, and beyond. This podcast is an invaluable resource for anyone interested in understanding how innovation is shaping the future of pharmacovigilance. Each episode promises insightful discussions, stimulating ideas, and the chance to keep abreast with the latest trends and issues in the field.
Join us on this journey, deciphering the complex world of pharmacovigilance in an accessible and engaging manner.
12 Episodes
Reverse
Embark on a captivating journey with Nicole Baker, the pioneering CEO of Biologit, as she shares her remarkable transition from academia to the forefront of pharmacovigilance on Truliant Talks. Nicole's narrative is not just about her personal evolution but also serves as an illuminating guide through the labyrinth of safety regulations and drug monitoring. Her candid conversation is a deep dive into the importance of patient safety, the impact of regulatory shifts, and the ever-present need ...
Embark on a transformational trek with Bill Ringbloom, AstraZeneca's Head of Global Patient Safety Technical Solutions as he shares his unconventional career trajectory from the financial chaos of 2008 to the cutting edge of pharmacovigilance. With a treasure trove of experience spanning IT, finance, and project management, Bill's insights shed light on the value of adaptable skill sets in the ever-evolving pharmaceutical domain. Tune in and uncover how the fusion of these diverse abilities i...
Embark on an enlightening expedition, as we navigate the vital intricacies of pharmacovigilance and risk management alongside Tom Nichols, zoologist turned PV aficionado and Director of Drive Phase PV. Tom regales us with his unexpected but inspiring foray into the world of drug safety, stemming from a keen interest in epidemiology. His captivating tales underscore the importance of PV in delivering life-saving therapies to market, particularly through his work with Clozapine, an anti-psychot...
Discover the intricate world of pharmacovigilance as Colleen Walsh, the Vice President of Global Patient Safety Operations at Alnylam, unveils her personal journey through the ever-evolving landscape of patient safety. In this enthralling episode of Innovation and the Future of Pharmacovigilance, I sit down with Colleen to unravel the complexities she's encountered, from the pivotal Tysabri incident at BioGen to leading R&D compliance at Alexion. Her story is a testament to the resilience...
Embark on an insightful exploration of pharmacovigilance with me, Indy Ahluwalia, as I sit down with industry trailblazer Rishi Chopra on Truliant Talks. Witness the fascinating narrative of Rishi's transition from biochemistry academia to becoming an instrumental figure in the pharmacovigilance space. His candid recount of the early days at Roche, where a nurturing community played a crucial role in his growth, sets the stage for a discussion full of personal anecdotes and pivotal moments th...
Embark on a journey through the dynamic world of pharmacovigilance with Michael Braun-Boghos, the seasoned Senior Director of Safety Strategy at Oracle. In our first episode of the season, Michael unpacks his three-decade odyssey from the analog days of adverse event forms to the digital frontier of pharmacovigilance. As we traverse his career landscape, the evolution from paper trails to strategic IT roles unfolds, highlighting pivotal shifts and the integrative prowess of systems like...
Prepare to have your perceptions of pharmacovigilance revolutionized as we're joined by the trailblazing co-founders of Truliant Consulting. We're peeling back the layers of AI's profound impact on the pharmaceutical industry, revealing how 2023's tech leaps are changing the game for drug safety. From the fascinating convergence of wearables and social media data to the necessity of keeping a laser focus on patient safety, this episode is a treasure trove of insights into the tools and succes...
Today's conversation comes alive with Tony De Sousa, the Global Head of Countries and Regions at Novartis, leading the discourse on a fascinating journey through the world of pharmacovigilance. Tony's intriguing journey from nursing to becoming a significant player in one of the world's largest pharmaceutical companies is sure to captivate you. We delve deep into the evolution of PV, contemplating the influence of European regulations and the complexities of leading a global team.But that's n...
Ever wondered how a company navigates the complexities of Pharmacovigilance (PV)? Catherine Kenny, managing partner and co-founder of Signal Pharma Experts, takes us on an enlightening journey through it all. With years of experience spanning from a generics company to a director and head of Benefit Risk at Diamond Pharma Services, Catherine shares her invaluable insights into the intriguing world of PV.Does the prospect of smaller firms utilizing AI, in the face of budgetary and resource lim...
Imagine stepping into the world of pharmacovigilance with Sue Rees, founder of Sue Rees Consultancy, who has graced the industry for over three decades. As we stroll down memory lane, we relive Sue's fascinating progression from her rookie days at Smith, Kline & French's adverse events department to her critical QPPV roles across the continents. We unravel the compelling narrative of how Brexit prompted Sue's entrepreneurial journey and her contributions to the education sector.Together w...
1Feeling intimidated by the thought of AI transforming the world of pharmacovigilance? Join us as we sit down with Fraser McCullum, founder of Imagine Pharmacovigilance Limited, who has spent over 20 years navigating the dynamic landscape of this industry. From his time as a bench scientist to establishing his own company, Fraser offers an insightful perspective on case processing to signal detection, and the future of risk management in pharmacovigilance. Our conversation also delves int...
Welcome to Truliant Talks, your definitive source for the world of pharmacovigilance amd risk management.As we enter an era defined by innovation and technological advancement, Truliant Talks is proud to announce a new podcast series, 'Innovation and the Future of Pharmacovigilance'.This holistic series will tackle every perspective of pharmacovigilance - from the role of regulators, the importance of vendors, to embracing AI, data privacy, and much more.We'll feature leaders, innovators, and...
Comments
Download from Google Play
Download from App Store
United States